GSDMD and metabolic dysfunction-associated steatotic liver disease: In addition, DK could decrease the expression of NLRP3, ASC, caspase-1, GSDMD, and cleaved-GSDMD to improve NAFLD in vivo. The pyroptotic cell numbers in the liver were increased by HFD and decreased after treatment with DK.